Long-term expression of human adenosine deaminase in vascular smooth muscle cells of rats: a model for gene therapy.

AUTOR(ES)

Lynch, C M

RESUMO

Gene transfer into vascular smooth muscle cells in animals was examined by using recombinant retroviral vectors containing an Escherichia coli beta-galactosidase gene or a human adenosine deaminase (adenosine aminohydrolase, EC 3.5.4.4) gene. Direct gene transfer by infusion of virus into rat carotid arteries was not observed. However, gene transfer by infection of smooth muscle cells in culture and seeding of the transduced cells onto arteries that had been denuded of endothelial cells was successful. Potentially therapeutic levels of human adenosine deaminase activity were detected over 6 months of observation, indicating the utility of vascular smooth muscle cells for gene therapy in humans.

Documentos Relacionados

• Gene therapy for long-term expression of erythropoietin in rats.
• Long-term expression of human adenosine deaminase in mice transplanted with retrovirus-infected hematopoietic stem cells.
• Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells.
• In defence of APTT control of long-term anticoagulant therapy.
• Ribozyme rescue of photoreceptor cells in P23H transgenic rats: Long-term survival and late-stage therapy